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Hemolysins are important virulence factors for many bacterial pathogens, including 23 
Serratia marcescens. The role of the major hemolysin gene in the insect pathogen Serratia sp. 24 
SCBI was investigated using both forward and reverse genetics approaches. Introduction of the 25 
major hemolysin gene into Escherichia coli resulted in a gain of both virulence and hemolytic 26 
activity. Inactivation of this hemolysin in Serratia sp. SCBI resulted in loss of hemolysis, but did 27 
not attenuate insecticidal activity. Unexpectedly, inactivation of the hemolysin gene in Serratia 28 
sp. SCBI resulted in significantly increased motility as well as increased antimicrobial activity. 29 
qRT-PCR analysis of mutants with a disrupted hemolysin gene showed a dramatic increase in 30 
mRNA levels of a nonribosomal peptide synthetase gene, swrA, which produces the surfactant 31 
serrawettin W2. Mutation of the swrA gene in Serratia sp. SCBI resulted in highly variable 32 
antibiotic activity, motility, virulence and hemolysis phenotypes that were dependent on the site 33 
of disruption within this 17.75 KB gene. When introduced into E. coli, swrA increases rates of 34 
motility and confers antimicrobial activity. While it is unclear how inactivation of the major 35 
hemolysin gene influences expression of swrA, these results suggest swrA plays an important 36 
role in motility and antimicrobial activity in Serratia sp. SCBI. 37 
IMPORTANCE 38 
The opportunistic gram-negative bacteria of the genus Serratia are found widespread in the 39 
environment and can cause human illness. Comparative genomics analysis between S. 40 
marcescens and a new Serratia species from South Africa, termed SCBI, shows that these two 41 
organisms are closely related, but differed in pathogenesis. S. marcescens kills Caenorhabditis 42 
nematodes, while Serratia sp. SCBI is not harmful and forms a beneficial association with them. 43 
This distinction presented the opportunity to investigate potential differences in the regulation of 44 
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common virulence mechanisms between these two species. With the emergence of antibiotic 45 
resistant microorganisms, there is a widespread need to understand the regulation of 46 
pathogenesis. The significance of this study is the presentation of evidence for cross-pathway 47 
regulation of virulence factors and how elimination of one mechanism may be compensated by 48 
up-regulation of others.  49 
 50 
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 Members of the genus Serratia are found widespread around the globe and are well 55 
known for their roles as insect pathogens (1, 2). A newly recognized Serratia species, termed 56 
South African Caenorhabditis briggsae Isolate (SCBI), was identified following its isolation 57 
from the nematode C. briggsae KT0001 (3). These C. briggsae KT0001 nematodes were 58 
recovered from soil samples through Galleria mellonella (the greater wax moth) larvae bait traps 59 
in three provinces in South Africa (3). The microbe-nematode complex between Serratia sp. 60 
SCBI and C. briggsae KT001 represents a potential emerging entomopathogenic association. 61 
Only a few Serratia species are known to use a nematode partner to establish an infection in an 62 
invertebrate host (4, 5). Serratia sp. SCBI demonstrates similar insect-pathogenic capabilities as 63 
other Serratia invertebrate pathogens with CFUs of <1,000 resulting in mortality in G. 64 
mellonella and Manduca sexta (tobacco horn worm) larvae following intra-hemocoelic injection 65 
(3, 6, 7). Comparative genomic analysis shows that Serratia sp. SCBI is closely related to 66 
Serratia marcescens Db11, a spontaneous streptomycin resistant mutant of S. marcescens Db10 67 
(8). S. marcescens Db11 is a broad host range pathogen (9-11) and shares many physiological 68 
characteristics with Serratia sp. SCBI (7). Despite similarity in over 85% of open reading 69 
frames, colonization of Caenorhabditis nematodes by these two Serratia spp. results in very 70 
distinct outcomes, with Serratia sp. SCBI exerting no harmful effects while S. marcescens Db11 71 
kills the nematode within seven days (8).  72 
Hemolytic activity is a known virulence factor of S. marcescens Db11 that is essential for 73 
pathogenesis against Caenorhabditis elegans and Drosophila melanogaster (10). Hemolysis by 74 
S. marcescens is primarily due to the pore-forming toxin ShlA, which is transcribed within the 75 
same operon as its activator and exporter, ShlB (12). Together ShlA and ShlB act as a two-76 
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partner secretion system (13) . In comparison, Serratia sp. SCBI contains a two-gene operon, 77 
containing a hemolysin activator protein and a major hemolysin gene, homologous to shlBA of S. 78 
marcescens Db11 (8). The major hemolysin gene of Serratia sp. SCBI shares 95% identity with 79 
shlA, indicating these two hemolysins likely share the same function. However, given their 80 
contrasting effects on Caenorhabditis hosts it is possible that regulation of hemolytic activity 81 
differs between S. marcescens Db11 and Serratia sp. SCBI.  82 
Temperature is an important environmental factor that can influence activity of essential 83 
virulence factors. A number of virulence-associated genes are downregulated in S. marcescens at 84 
37C, including hemolysis. Optimal hemolysis and swarming motility (rapid, coordinated 85 
translocation of a bacterial population) is observed between 28-30C in S. marcescens, with a 86 
sharp decrease in both activities at 37C (14-17). The mechanism behind the temperature 87 
regulation of both hemolysis and motility has been elucidated in S. marcescens CH-1(16). At 88 
higher temperatures, such as 37C, a two-component system, termed RssAB, is activated. RssA 89 
serves as the sensor kinase and RssB the response regulator. Once phosphorylated at 37C, RssB 90 
block expressions of the transcriptional regulators flhDC. FlhDC regulates the expression of 91 
genes involved in flagella formation, chemotaxis, and cell division (18-20). FlhDC also 92 
positively regulates the hemolysin operon, shlBA (16). Therefore, with repression of flhDC at 93 
37C by RssB, shlA is not expressed, resulting in loss of both swarming motility and hemolytic 94 
activity at 37C and a switch to biofilm formation. RssB also negatively regulates expression of 95 
the mannose-6-phosphate isomerase manA, which in turn positively regulates the biosurfactant 96 
serrawettin W1 (21). Serrawettin W1 is critical for reducing surface tension when S. marcescens 97 
is actively swarming (22) and therefore its repression at 37C also contributes to the loss of 98 
swarming motility at this temperature. 99 
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Serratia spp. can produce one of three types of distinct serrawettins and these compounds 100 
are unique to Serratia. Termed serrawettin W1, W2 or W3, these nonionic biosurfactants often 101 
play an important role in swarming motility but can also contribute to hemolysis (22-25). 102 
Serrawettin W1, also known as serratamolide, contributes to swarming motility, is a broad-103 
spectrum antibiotic, and is hemolytic to sheep and murine red blood cells. Furthermore, 104 
serrawettin W1 is cytotoxic to human airway and corneal limbal epithelial cells (25). S. 105 
marcescens Db10 produces serrawettin W2, which is encoded by the massive 17,781 bp 106 
nonribosomal peptide synthetase (NRPS) swrA (26). S. marcescens Db10 serrawettin W2 is 107 
essential for swarming motility, has hemolytic properties, and also acts as a repellent towards 108 
Caenorhabditis nematodes. Serrawettin W2 also has antimicrobial activity towards 109 
Staphylococcus aureus (27). The genome of Serratia sp. SCBI contains a 17,775 bp gene with 110 
over 96% identity to the serrawettin W2 gene found in S. marcescens Db10 (8). This similarity in 111 
gene sequence suggests that serrawettin W2 produced by Serratia sp. SCBI could exhibit the 112 
same function, but it has not yet been investigated. 113 
In sharp contrast to S. marcescens, Serratia sp. SCBI does not exhibit a reduction in the 114 
rate of hemolysis or dramatic reductions in swarming or swimming (movement along a nutrient 115 
gradient by use of flagella) motility at 37C (7). This indicates that regulation of hemolysis, and 116 
even motility, is likely different between these two species. To try and elucidate the mechanisms 117 
involved in the regulation and activity of hemolysis in Serratia sp. SCBI, hemolytic activity was 118 
investigated utilizing both forward and reverse genetics approaches. Results indicated that while 119 
shlA confers the ability for Escherichia coli to kill M. sexta, it is not a critical virulence factor for 120 
Serratia sp. SCBI. Interestingly, it was observed that hemolysis-deficient Serratia sp. SCBI 121 
mutants demonstrated hyper-swarming and hyper-swimming phenotypes and showed an increase 122 
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in antimicrobial activity. Therefore, the mechanism by which the hemolysis mutants were hyper-123 
motile was investigated.  124 
RESULTS 125 
Identification and genetic analysis of E. coli fosmid clones with a gain of pathogenicity. To 126 
identify virulence factors that cause mortality to M. sexta larvae, a Serratia sp. SCBI fosmid 127 
library was constructed in E. coli EPI300 using the pCC1FOS vector (Epicentre). A total of 128 
396 E. coli clones were individually injected into 3
rd
 instar M. sexta larvae to identify fosmids 129 
carrying virulence genes. A total of 25 clones were selected and confirmed to have a gain of 130 
pathogenicity. When compared to the control group injected with wild-type E. coli EPI300, the 131 
25 clones caused mortality, delays in development, and/or change of larvae color (from green to 132 
pink, suggesting these larva were unhealthy). All 25 fosmids were end-sequenced and 133 
sequencing results were blasted against the Serratia sp. SCBI genome to identify the genes in 134 
each insecticidal E. coli clone. Out of the 25 pathogenic E. coli clones, one fosmid clone, termed 135 
A1-A8, carried the 4,827 bp Serratia sp. SCBI major hemolysin gene shlA (SCBI_3479) and its 136 
accompanying 1,680 bp exporter shlB (SCBI_3480) (Table S2 in Supplementary Materials). 137 
Because hemolytic activity is a major virulence factor in S. marcescens, fosmid clone A1-A8 138 
was the focus of this study while the remaining pathogenic clones were stored for future analysis.  139 
Fosmid clone A1-A8 killed an average of 73% of M. sexta larva injected (Figure 1A) and 140 
demonstrated a gain of hemolytic activity, though the rate of hemolysis was less than that of 141 
wild-type Serratia sp. SCBI (Figure 1B).  Lambda Red recombination was utilized to disrupt the 142 
shlA gene on fosmid A1-A8. Removal of a 3,132 bp portion of the shlA gene beginning 42 bp 143 
downstream of the start codon, resulted in reversion to the non-virulent, non-hemolytic 144 
phenotype of wild-type E. coli EPI300. Therefore, shlA was responsible for both the gain of 145 
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hemolytic activity and insecticidal activity in fosmid clone A1-A8. 146 
Inactivation of the shlA gene in Serratia sp. SCBI results in a significant loss of hemolytic 147 
activity yet had no effect on virulence. Because the Serratia sp. SCBI shlA gene conferred 148 
insecticidal activity in E. coli, a Serratia sp. SCBI miniHimar RB1 transposon mutant library of 149 
2,100 clones was generated and screened for defects in hemolytic activity to determine if loss of 150 
hemolysis would have a significant impact on virulence. The 2,100 transposon mutants were 151 
assayed for their ability to lyse sheep red blood cells (SRBCs) and seven mutants with defective 152 
hemolytic activity were identified. Of these seven mutants, four mutants (1-C4, 6-E3, 8-E6, and 153 
10-F8) had a complete loss of activity and the remaining three mutants (18-A11, 22-C11 and 22-154 
H3) demonstrated variable reductions in the rate of hemolysis (Figure 2A). Genetic analysis of 155 
these mutants showed that five had the transposon insertion at different points within shlA 156 
(SCBI_3479). The four mutants with a total loss of hemolytic activity (1-C4, 6-E3, 8-E6, and 10-157 
F8) all had hits within the first 1,500 bp of shlA (Figure 2B). The shlA mutant 18-A11 was the 158 
only clone with a hit within shlA that retained some activity and had the transposon insertion 159 
2,597 bp downstream of the start codon. Mutant 22-C11 had the insertion in a putrescine 160 
importer (SCBI_0418) and mutant 22-H3 had the transposon hit a non-coding region between a 161 
5’nucleosidase (SCBI_1151) and a cytochrome d ubiquinol oxidase subunit (SCBI_1152).  162 
All seven hemolysis mutants (1-C4, 6-E3, 8-E6, 10-F8, 18-A11, 22-C11, and 22-H3) 163 
were subsequently assayed for virulence in M. sexta. Despite the loss or reduction of hemolytic 164 
activity, all seven hemolysis mutants killed larva at a similar rate as wild-type Serratia sp. SCBI. 165 
The LT50 values of wild-type Serratia sp. SCBI and mutants 1-C4, 6-E3, 8-E6, 10-F8, 18-A11, 166 
22-C11, and 22-H3 were 2.71, 3.35, 3.30, 3.23, 3.37, 2.56, 3.42, and 3.75 days, respectively. 167 
These results indicate that while shlA was enough to confer insecticidal activity to E. coli, it is 168 
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not required for insect pathogenesis in Serratia sp. SCBI. 169 
Inactivation of the shlA gene in Serratia sp. SCBI results in hyper-motility. To determine if 170 
any other physiological functions were affected by alterations in hemolytic activity, all seven 171 
Serratia sp. SCBI hemolysis mutants were assayed for swarming and swimming motility. All 172 
five shlA mutants (1-C4, 6-E3, 8-E6, 10-F8 and 18-A11) began swarming earlier and at a faster 173 
rate than wild-type Serratia sp. SCBI (Figure 3A). By 18 h, these five mutants had nearly 174 
swarmed across the entire 88 mm plate, at which time wild-type Serratia sp. SCBI and mutants 175 
22-C11 and 22-H3 had not yet begun to swarm (Figure 3D). In addition, shlA mutants 1-C4, 6-176 
E3, 8-E6, 10-F8 and 18-A11 were able to swarm on hard agar (1.5%), with swarm ring diameters 177 
averaging 30.3 ± 3.6  mm following 48 h of incubation at 28°C (Figure 3B, D). Wild-type 178 
Serratia sp. SCBI and mutants 22-C11 and 22-H3 were unable to swarm on 1.5% agar. When 179 
analyzed for swimming behavior, all five shlA mutants showed increased rates of movement 180 
(Figure 3C). On average, these shlA mutants had a swim ring diameter between 55.3 and 67.3 181 
mm following 8 h of incubation at 37°C compared to wild-type Serratia sp. SCBI which had an 182 
average swim ring diameter of 44.3 + 0.5 mm (Figure 3D). Mutants 22-C11 and 22-H3 showed 183 
no alterations in swimming behavior compared to wild-type Serratia sp. SCBI. 184 
Inactivation of the shlA  gene in Serratia sp. SCBI also results in increased antimicrobial 185 
activity. Next, the shlA mutants were assayed for antimicrobial activity against Micrococcus 186 
luteus. These mutants had increased antibiotic activity when compared with wild-type Serratia 187 
sp. SCBI (Table 2). The shlA mutants 1-C4, 6-E3, 8-E6, 10-F8, and 18-A11 had average clearing 188 
zones of 16.2, 15.9, 17.1, 16.8, and 16.1 mm with standard deviations between 1.05 and 2.36 189 
mm. In comparison, wild-type Serratia sp. SCBI had an average clearing zone of 14.1+ 1.76  190 
mm.  191 
 o
n










Inactivation of the flhC gene resulted in loss of motility, but had no effect on hemolytic 192 
activity. Expression of shlBA is under control of FlhDC in S. marcescens CH-1(16). To 193 
determine if FlhDC may be involved in regulation of shlBA in wild-type Serratia sp. SCBI, and 194 
therefore somehow involved in the hyper-motile phenotypes of the five shlA mutants, the 195 
Serratia sp. SCBI miniHimar RB1 transposon mutant library was screened for defects in 196 
swimming motility in an attempt to find a mutant with an insertion in the flhDC operon. Out of 197 
2,100 mutants screened, 16 with defective swimming were identified. Mutant 12-H4, which had 198 
completely abolished swimming motility, was found to contain the transposon insertion in flhC 199 
(SCBI_2840). Mutant 12-H4 had the transposon insert 354 bp downstream of the start site of 200 
flhC, which resulted in total loss of swarming and swimming motility (Figure 4A, B). In contrast 201 
to what is observed in S. marcescens flhC mutants, loss of flhC had no effects on hemolytic 202 
activity in Serratia sp. SCBI (Figure 4C).  203 
shlA mutants showed a significant increase in swrA expression. To further investigate the 204 
genes responsible for the hyper-swarming phenotype observed in the Serratia sp. SCBI shlA 205 
mutants, qRT-PCR was utilized to measure mRNA levels for genes predicted to be involved in 206 
either flagella or surfactant production. The expression of flhD (SCBI_2841), fliC (SCBI_2820), 207 
and swrA (SCBI_4162) in the Serratia sp. SCBI hemolysis mutants during swarming was 208 
assayed. FlhD is a regulator of flagella genes, FliC is a flagellar protein, and SwrA is a NRPS 209 
hypothesized to catalyze production of the surfactant serrawettin W2. At a swarm ring diameter 210 
of 40 mm, qRT-PCR analysis showed the shlA mutants 1-C4, 6-E3, 8-E6, 10-F8, and 18-A11 all 211 
had a significant increase in swrA mRNA levels, between a 14.7 and 22.4-fold change difference, 212 
compared to wild-type Serratia sp. SCBI (Figure 5A). There were no differences in mRNA 213 
levels for the flhD or fliC genes between the mutants and wild-type Serratia sp. SCBI. To 214 
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investigate possible changes in gene expression over different stages of swarming, mRNA levels 215 
of flhD, fliC, and swrA genes from shlA mutant 6-E3 and wild-type Serratia sp. SCBI were 216 
compared at 20 mm, 40 mm, and 80 mm. The level of swrA mRNA was highest in mutant 6-E3 217 
at the early stages of swarming (20 mm) and was significantly higher than wild-type Serratia sp. 218 
SCBI at all stages of swarming (Figure 5B). In shlA mutant 6-E3, the level of swrA mRNA 219 
decreased as the swarming colony expanded. At no point during the swarming process did the 220 
levels of flhD and fliC mRNA differ significantly between shlA mutant 6-E3 and wild-type 221 
Serratia sp. SCBI.  222 
Mutation of different sites within the 17,775 bp swrA gene resulted in various changes in 223 
antibiotic production. Because the Serratia sp. SCBI shlA mutants showed increased swrA 224 
mRNA levels, and swrA is responsible for the production of the biosurfactant serrawettin W2, 225 
which has antimicrobial activity (27), the Serratia sp. SCBI miniHimar RB1 transposon mutant 226 
library was screened for mutants with altered antibiotic activity in order to try and identify a 227 
mutant with a defective swrA gene. Mutants 1-A4, 13-G2 and 11-B8 were initially identified as 228 
having altered antibiotic activity against M. luteus and rescue cloning showed that all three 229 
mutants had the transposon insertion in swrA (SCBI_4162). Subsequent confirmation 230 
experiments demonstrated that swrA mutant 11-B8, which had the transposon insertion at the 231 
16,198 bp position, had wild-type levels of antibiotic activity with an average clearing zone of 232 
13.7 + 0.5 mm. In contrast, swrA mutants 1-A4 and 13-G2 showed no antimicrobial activity 233 
against M. luteus (Figure 6C). The swrA mutant 1-A4 had the insertion at the 8,700 bp position 234 
of swrA while swrA mutant 13-G2 had the insertion at the 10,242 bp position (Figure 6A). Figure 235 
6B shows the different domains of the NRPS SwrA. The swrA mutant 11-B8 hit within an amino 236 
acid adenylation domain, while mutants 1-A4 and 13-G2 did not hit any putative domains within 237 
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swrA.  238 
The swrA mutants displayed variable motility phenotypes. Because SwrA is hypothesized to 239 
catalyze the production of the surfactant serrawettin W2, swrA mutants 1-A4, 13-G2, and 11-B8 240 
were assayed for swimming and swarming motility to determine if there were any defects in 241 
motility. It was expected that all three swrA mutants would have delayed or abolished swarming 242 
motility. However, the results were highly variable and dependent on the site of transposon 243 
insertion. On 0.65% agar, swrA mutant 1-A4 was defective in swarming motility (Figure 7A, B, 244 
D). The swrA mutant 13-G2 did swarm on 0.65% agar, but the rate of movement was delayed 245 
compared to wild-type Serratia sp. SCBI (Figure 7A). The swrA mutant 13-G2 did not swarm on 246 
1.05% agar (Figure 7B, D). The swrA mutant 11-B8 had slightly decreased rates of swarming 247 
motility on 0.65% and 1.05% agar compared to wild-type Serratia sp. SCBI (Figure 7A, B, D). 248 
All three swrA mutants demonstrated similar defects in swimming motility as was seen in 249 
swarming motility (Figure 7C, D). The swrA mutant 1-A4 had an average swim ring diameter of 250 
only 11.0 + 0.8 mm compared to wild-type Serratia sp. SCBI, which averaged a swim ring 251 
diameter of 45.7 + 1.7 mm following 8 h of incubation at 37°C. The swrA mutants 13-G2 and 252 
11-B8 had reduced rates of swimming motility with swim ring diameters of 18.7 + 2.5 mm and 253 
25.7 + 3.3 mm, respectively. While these results demonstrate that swrA is important in both 254 
swarming and swimming motility, this gene is highly complex and appears to have domains 255 
important in self-regulation. 256 
The swrA mutants demonstrated variable rates of hemolytic activity and virulence. To 257 
determine if disruption of the swrA gene in Serratia sp. SCBI had any impact on virulence, swrA 258 
mutants 1-A4, 13-G2, and 11-B8 were individually injected into 3
rd
 instar M. sexta larvae and 259 
monitored for mortality over a seven day period. The swrA mutant 13-G2 killed M. sexta at a 260 
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similar rate as wild-type Serratia sp. SCBI with LT50 values of 1.71 and 1.18 days, respectively 261 
(Figure 8A). The swrA mutant 11-B8 killed at a slightly reduced rate with an LT50 value of 2.93 262 
days. swrA mutant 1-A4 was less virulent than wild-type Serratia sp. SCBI, killing only 40% of 263 
larvae injected with a LT50 value of 7.28 days. All three swrA mutants were also assayed for 264 
hemolytic activity. The swrA mutants 13-G2 and 11-B8 demonstrated slightly reduced levels of 265 
hemolytic activity compared to wild-type Serratia sp. SCBI (Figure 8B), but this effect is likely 266 
due to a slight decrease in growth rate (Figure 8C). The swrA mutant 1-A4 had completely 267 
abolished hemolysis over 4 h against SRBCs.  268 
Complementation of the major hemolysin gene in mutant 1-C4 restored wild-type 269 
phenotypes. The major hemolysin gene was cloned and tested for complementation in shlA 270 
mutant 1-C4. Since inactivation of shlA resulted in severely attenuated hemolytic activity, hyper-271 
motility, and hyper-antimicrobial activity, it was hypothesized that introduction of shlA on a 272 
multi-copy plasmid would restore all these phenotypes back to wild-type levels. Since the other 273 
shlA mutants (6-E3, 8-E6, 10-F8, and 18-A11) demonstrated similar phenotypes, 274 
complementation was performed only on one mutant. Plasmid pBAD33 (Cm
r
) was introduced 275 
into both wild-type Serratia sp. SCBI and shlA mutant 1-C4 as controls. pBAD33-Hemol was 276 
introduced into both wild-type Serratia sp. SCBI and shlA mutant 1-C4. Wild-type Serratia sp. 277 
SCBI, shlA mutant 1-C4, the control transformants containing pBAD33, and the complemented 278 
wild-type Serratia sp. SCBI and shlA mutant 1-C4 were all assayed for hemolytic activity, 279 
swarming and swimming motility, and antimicrobial activity against M. luteus (Table 3). The 280 
presence of pBAD33 without insert did not significantly change the phenotypes of wild-type 281 
Serratia sp. SCBI or shlA mutant 1-C4. The presence of pBAD33-Hemol did not significantly 282 
change the physiology of wild-type Serratia sp. SCBI, even in terms of hemolytic activity. The 283 
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presence of pBAD33-Hemol did restore the phenotypes of shlA mutant 1-C4 back to wild-type 284 
levels. The percentage of SRBCs lysed after 4 h of incubation changed from 2.8% to 86.5% 285 
between the mutant and the complemented mutant, respectively. Swarming and swimming rates 286 
decreased back to wild-type levels in complemented shlA mutant 1-C4. Furthermore, 287 
antimicrobial activity was restored to wild-type level in complemented shlA mutant 1-C4, with 288 
radii of the clearing zones dropping from an average of 16.9 mm down to 13.2 mm.  289 
Introduction of swrA into E. coli caused significant increases in both swarming and 290 
swimming motility as well as increased antimicrobial activity. An E. coli fosmid clone, 291 
termed A1-F2, was identified in the M. sexta gain of pathogenesis screen. Fosmid clone A1-F2 292 
killed approximately 20% of M. sexta larva following intra-hemocoelic injection. End 293 
sequencing of this fosmid showed that it contained swrA (Table S3 in Supplementary Materials). 294 
When assayed for swimming motility, clone A1-F2 had an average swim ring diameter of 55.0 + 295 
5.0 mm, at which point wild-type E. coli EPI300 had not yet begun to swim (Figure 9A, C). 296 
Fosmid clone A1-F2 was also able to swarm on LB plates containing 0.5% agar. Following 18 h 297 
of incubation at 28°C, fosmid clone A1-F2 had swarmed across the entire plate (Figure 9B). 298 
Swarming was optimal at 28°C as fosmid clone A1-F2 had average swarm ring diameters of only 299 
19.5 + 1.0 mm and 28.5 + 1.2 mm at 18 h at 22°C and 37°C, respectively. However, E. coli 300 
fosmid clone A1-F2 had swarmed across the entire plate by 24 h at both 22°C and 37°C. E. coli 301 
EPI300 was not capable of swarming at any temperature on LB plates containing 0.5% agar. 302 
When assayed for hemolysis, fosmid clone A1-F2 showed no hemolytic activity (data not 303 
shown). When tested for antimicrobial activity, fosmid clone A1-F2 showed antimicrobial 304 
activity against M. luteus, but its activity was significantly lower than wild-type Serratia sp. 305 
SCBI (see Table 2). Fosmid clone A1-F2 produced a clearing zone of 5.9 + 1.56 mm and wild-306 
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type Serratia sp. SCBI had a clearing zone of 14.1 + 1.76 mm. Wild-type E. coli EPI300 had no 307 
antimicrobial activity.  308 
Physiochemical analysis of serrawettin W2. MALDI-MS analysis of wild-type Serratia sp. 309 
SCBI cells led to the detection of a compound with a mass of m/z 754.43697 [M+Na]
+
 leading to 310 
a sum formula of C38H61O9N5 (calc. m/z 754.43615 [M+Na]
+
, ∆ppm 1.083). This sum formula is 311 
in accordance with serrawettin W2 (22). Results showed that m/z 754.44 [M+Na]
+
 was also 312 
produced by shlA mutant 1-C4 and E. coli fosmid clone A1-F2 (Figure S1). MALDI-MS
2
 of m/z 313 
754.44 [M+Na]
+
 (Figure S2) revealed a neutral loss fragmentation pattern similar to what has 314 
been reported for serrawettin W2 (22). Based on these findings, we conclude that m/z 754.44 315 
[M+Na]
+
 produced by Serratia sp. SCBI, shlA mutant 1-C4, swrA mutant 11-B8, and E. coli 316 
fosmid clone A1-F2 is serrawettin W2 or a close derivative thereof.     317 
 318 
DISCUSSION 319 
The hemolysin ShlA is an important virulence factor in S. marcescens (16, 28-30). Transposon 320 
insertion in the shlBA operon in S. marcescens Db11 results in a significant attenuation of 321 
virulence towards C. elegans, D. melanogaster, and a murine lung infection model (10). 322 
Inactivation of shlA in Serratia sp. SCBI, which shares 95% identity at the nucleic acid sequence 323 
level to the shlA gene of S. marcescens, resulted in complete loss of hemolytic activity when the 324 
transposon hit within the first 1,500 bp of the gene. Abolishment of hemolytic activity did not 325 
alter virulence towards M. sexta. In contrast to S. marcescens Db11, this result indicates that, 326 
hemolysis is not required for insecticidal activity by Serratia sp. SCBI. However, shlA does have 327 
toxic effects. Introduction of the Serratia sp. SCBI shlA gene, along with its activator shlB, into 328 
E. coli EPI300 on a fosmid resulted in both a gain of hemolytic activity and a gain of 329 
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pathogenesis. Deletion of shlA by lambda Red recombination confirmed that this hemolysin was 330 
responsible for the gain of insecticidal activity by E. coli. Therefore, while shlA does confer 331 
virulence in E. coli, it is not the driving factor of Serratia sp. SCBI pathogenesis.  332 
Interestingly, inactivation of shlA in Serratia sp. SCBI resulted in significantly increased 333 
rates of swarming and swimming motility as well as increased antimicrobial activity. 334 
Furthermore, in contrast to wild-type Serratia sp. SCBI, these mutants were capable of swarming 335 
on hard agar. This phenomenon has no precedence in the literature and therefore several 336 
approaches were used to try and pinpoint the cause of increased motility in these mutants. Since 337 
FlhDC is a regulator of hemolytic activity in S. marcescens, one goal was to determine if FlhDC 338 
is a positive regulator of hemolytic activity in Serratia sp. SCBI. It was hypothesized that if 339 
FlhDC was important in regulating shlA, the hyper-motile phenotype seen in the hemolysis 340 
mutants was result of FlhDC activity. Screening of the miniHimar RB1 transposon library 341 
uncovered a mutant (12-H4) with the insertion in flhC. The flhC mutant 12-H4 had abolished 342 
swimming and swarming motility, yet demonstrated wild-type hemolysis. This result indicated 343 
that hemolysis is regulated differently in Serratia sp. SCBI compared to S. marcescens, in which 344 
inactivation of flhDC results in loss of hemolytic activity (16).  345 
Expression analysis by qRT-PCR provided further evidence that FlhDC was not 346 
responsible for the hyper-motility in the shlA mutants. When the expression levels of flhD and 347 
fliC were compared between the hyper-swarmer hemolysis mutants and wild-type Serratia sp. 348 
SCBI, no differences were found. These results provided evidence that the increased rates of 349 
motility in shlA mutants 1-C4, 6-E3, 8-E6, 10-F8, and 18-A11 were not flagella-driven. Instead, 350 
it was the expression of swrA that appeared to be responsible. SwrA is a large NRPS gene that 351 
catalyzes production of the surfactant serrawettin W2 in S. marcescens strains Db11 and Db10 352 
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(26, 27). Serrawettin W2 is critical for swarming, as it reduces surface tension along the edges of 353 
the swarm colony, and also shows antimicrobial activity against S. aureus. All five Serratia sp. 354 
SCBI shlA mutants had levels of swrA mRNA 15-22X higher than wild-type Serratia sp. SCBI. 355 
These mutants also had increased antimicrobial activity against M. luteus compared to wild-type 356 
Serratia sp. SCBI. When analyzed by mass spectrophotometry, shlA mutant 1-C4 was confirmed 357 
to overproduce serrawettin W2, further supporting the qRT-PCR data that this biosurfactant 358 
accounted for the increased motility and antibiotic activity. Though only shlA mutant 1-C4 was 359 
analyzed, it is likely that all five shlA mutants overproduce serrawettin W2. Further analysis of 360 
shlA mutant 6-E3 showed that expression of swrA was highest during the early stages of 361 
swarming and decreased as the swarm colony moved out across the plate.   362 
Screening of the miniHimar transposon mutant library for altered antibiotic activity 363 
against M. luteus identified three mutants (1-A4, 13-G2, and 11-B8) with the transposon 364 
insertion in swrA, providing evidence that serrawettin W2 has antimicrobial properties. However, 365 
antibiotic activity was not consistent in all three mutants. The swrA mutant 1-A4, which contains 366 
the transposon insertion towards the middle of swrA at the 8,700 bp position, had abolished 367 
antimicrobial and hemolytic activities. Furthermore, swrA mutant 1-A4 was completely non-368 
motile and virulence was severely attenuated. When the transposon was inserted a little further 369 
downstream in swrA at the 10,242 bp position, as seen in mutant 13-G2, there was no 370 
antimicrobial activity and rates of swimming and swarming motility were both significantly 371 
reduced. swrA mutant 11-B8, which contained the transposon insertion at the very end of swrA, 372 
did not show significant changes in antimicrobial activity, motility, hemolysis, or virulence when 373 
compared to wild-type Serratia sp. SCBI. Although the presence of wild-type shlA appears to 374 
regulate the production of SwrA, the results from swrA mutant 1-A4, most notably its non-375 
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hemolytic phenotype, suggests that SwrA may in turn regulate shlA expression. We hypothesize 376 
that this regulation would occur in an indirect manner.  377 
While a number of strains of S. marcescens carry a version of swrA, the swrA gene in S. 378 
marcescens Db10 is similar in both size (17,781 bp) and DNA sequence identity (96%) to the 379 
Serratia sp. SCBI swrA gene (26). Physiochemical analysis of Serratia sp. SCBI serrawettin W2 380 
strongly suggest that these two Serratia spp. produce a very similar cyclodepsipeptide which 381 
contains D-3-hydroxydecanoic acid and five amino acids (D-leucine, L-serine, L-threonine, D-382 
phenylalanine, and L-isoleucine) as it has been also determined by in silico analysis using the 383 
antismash program (31). The only difference phenotypically is that serrawettin W2 from S. 384 
marcescens Db10 shows hemolytic properties, but serrawettin W2 from Serratia sp. SCBI did 385 
not show any hemolysis against SRBCs. It is possible that the serrawettin W2 produced by 386 
Serratia sp. SCBI could be hemolytic towards other red blood cell types, such as human, due to 387 
differences in membrane compositions. Nevertheless, the serrawettins from both species are 388 
critical for swarming motility and antimicrobial activity.  389 
In S. marcescens strain MG1, the gene encoding swrA is significantly smaller, 390 
approximately 2.7 kb, but the final product is similar in structure to that produced in S. 391 
marcescens Db10 and Serratia sp. SCBI (26, 32, 33). The 2.7 kb swrA gene of S. marcescens 392 
MG1 is homologous to the beginning of swrA gene of both S. marcescens Db10 and Serratia sp. 393 
SCBI. However the larger size of swrA in both S. marcescens Db10 and Serratia sp. SCBI and 394 
the phenotypic data collected from the three SCBI swrA mutants indicates the entire gene is 395 
required for proper synthesis of SwrA. The differences in phenotypes between 1-A4, 13-G2, and 396 
11-B8 are likely due to the production of a truncated form of SwrA, each mutant with a different 397 
version of the lipopeptide. Further investigation into the function of the different modules in 398 
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swrA should provide insight into explaining the phenotypes of swrA mutants 1-A4, 13-G2, and 399 
11-B8. 400 
Introduction of the swrA gene into E. coli demonstrates how important serrawettin W2 is 401 
to motility and antimicrobial activity. Without swrA, E. coli EPI300 is unable to swarm on LB 402 
plates containing 0.5% agar. However with swrA, as seen in fosmid clone A1-F2, swarming does 403 
occur and is optimal at 28C. Clone A1-F2 swarmed across an entire plate within 18 h at 28C 404 
while it took a full 24 h for A1-F2 to swarm across the entire plate at 22C and 37C. Though E. 405 
coli EPI300 will swim in LB plates containing 0.2% agar, it occurs at a faster rate when 406 
transformed with swrA. Fosmid clone A1-F2 displayed swimming rates similar to wild-type 407 
Serratia sp. SCBI and had an average swim ring diameter of 55 mm after 8 h at 37C. E. coli 408 
EPI300 did not begin swimming within that time frame, however had swim rings of 55 mm or 409 
greater following incubation for 24 h at 37C. Though the swrA gene in S. marcescens Db10 had 410 
hemolytic properties (26), clone A1-F2 showed no hemolysis against SRBCs. Clone A1-F2 did, 411 
however, demonstrate antimicrobial activity, indicating that serrawettin W2 serves as both a 412 
wetting agent and antibiotic in Serratia sp. SCBI and likely contributes to its survival in 413 
polymicrobial environments. 414 
This study has highlighted several important differences between Serratia sp. SCBI and 415 
S. marcescens Db11. First, regulation of hemolytic activity is different between these two 416 
organisms. In contrast to S. marcescens, the global regulators FlhDC do not appear to have any 417 
role as a positive regulator of hemolysis in Serratia sp. SCBI. Also, hemolysis is not a 418 
requirement for insecticidal activity in Serratia sp. SCBI. These results are important for laying 419 
the groundwork into understanding how Serratia sp. SCBI has evolved as a mutualist of 420 
Caenorhabditis nematodes, while S. marcescens remains a pathogen of these nematodes. S. 421 
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marcescens Db11 relies on its hemolysin for pathogenesis towards both insects and nematodes. 422 
Yet, it is clear that Serratia sp. SCBI has a different repertoire of essential virulence factors for 423 
the killing of insects. The connection between shlA and swrA in Serratia sp. SCBI calls into 424 
question why these two genes, which do not reside near each other in the genome, have such 425 
strong effects on each other. SwrA clearly plays an important role in the motility of Serratia sp. 426 
SCBI and motility is often important in the ability of a bacterium to colonize a host. While 427 
further investigation on the mechanisms that Serratia sp. SCBI utilizes to colonize C. briggsae is 428 
needed, it is possible that swarming contributes to successful colonization of the nematode. 429 
During this time, the antimicrobial properties of serrawettin W2 would ward off other 430 
competitors within the intestine of the nematode. It is also important that during colonization of 431 
the nematode expression of shlA is repressed as it is likely that ShlA is harmful to the nematode. 432 
From the expression data collected from the 5 Serratia sp. SCBI shlA mutants (1-C4, 6-E3, 8-E6, 433 
10-F8, and 18-A11), disruption of shlA gene clearly affects swrA expression, and disruption of 434 
swrA at a specific location (as seen in swrA mutant 1-A4) influences hemolytic activity. 435 
Therefore, in order to both successfully colonize the nematode and carry out its role as an insect 436 
pathogen, Serratia sp. SCBI has evolved a regulatory system that ensures proper gene expression 437 
to carry out its dual lifestyle, and this system involves regulating the expression of shlA and 438 
swrA. 439 
In summary, the function of the Serratia sp. SCBI shlA gene and its role in virulence was 440 
elucidated. While ShlA produced by Serratia sp. SCBI is solely responsible for hemolytic 441 
activity, it appears to play a minor role in insect pathogenesis. Unexpectedly, those Serratia sp. 442 
SCBI transposon mutants with the major hemolysin gene inactivated were hyper-motile and 443 
demonstrated increased antimicrobial activity. These phenotypes were due to significantly 444 
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increased expression of the NRPS swrA. Mutants 22-C11 and 22-H3 had reduced hemolysis yet 445 
displayed no alterations in motility, suggesting that inactivation of the major hemolysin gene 446 
itself is responsible for the effects on swrA expression. Transposon mutagenesis of the swrA gene 447 
resulted in variable motility, antimicrobial, hemolytic and virulence phenotypes in Serratia sp. 448 
SCBI that were dependent on site of insertion. Introduction of swrA in E. coli resulted in 449 
significant increases in swarming and swimming motility and a gain of antimicrobial activity. 450 
The mechanism for how inactivation of shlA influences expression of this large NRPS warrants 451 
further investigation. Furthermore, investigation the function of the different modules of swrA 452 
should provide evidence as to how inactivation of different portions of this gene results in such 453 
varying phenotypes. Finally, this study provides evidence that, similar to other Serratia spp., 454 
both production of a biosurfactant and flagella are required for swarming motility. 455 
 456 
EXPERIMENTAL PROCEDURES 457 
Bacterial Strains and Growth Conditions. A complete list of all bacterial strains and plasmids 458 
used in this study are listed in Table 1. Bacteria were grown overnight at 37C in LB medium 459 
(1% tryptone, 0.5% yeast extract, 1% NaCl) with appropriate antibiotics when required. 460 
Bacterial Growth Assay. The growth of Serratia sp. SCBI mutants was determined at 28C 461 
using methods described previously (7). 462 
Fosmid Library Construction. The Serratia sp. SCBI fosmid library was constructed with the 463 
pCC1FOS vector using Epicentre’s CopyControlTM Fosmid Library Production Kit following 464 
manufacturer’s instructions (8).  465 
Gain of Pathogenicity Assay. A total of 396 fosmid clones were assayed for their ability to kill 466 
3
rd
 instar M. sexta larvae using methods described previously (7). Briefly, overnight bacterial 467 
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cultures were initially diluted to an OD600 of 1.0 in LB medium. The bacterial culture was further 468 
diluted several-fold to obtain an average CFU value of 2 x 10
5
 for each fosmid clone. For each 469 
diluted sample, 10 l was directly injected into the insect hemocoel by use of a sterilized 470 
Hamilton syringe. Serratia sp. SCBI was used as a positive control and E. coli EPI300 was used 471 
as a negative control. For all of the samples, including the controls, 3 larvae were used. The 472 
larvae were held individually with food for 7 days at 37C under a 16 h light/8 h dark cycle. The 473 
larvae were monitored for insect mortality or delays in insect development during that time 474 
period. Clones displaying gain of pathogenicity were confirmed by performing 3 biological 475 
replicates using 10 M. sexta larva for each assay and utilizing the same CFU value used for the 476 
initial screen. Mortality was measured as percentage of larvae killed by the bacteria relative to 477 
total number of larvae injected per sample.  478 
Sequencing Pathogenic Fosmids. Fosmids with gain of function for pathogenicity were isolated 479 









 primers. Fosmid gene location was determined 481 
using BLASTN against the Serratia sp. SCBI genome. The average size the fosmids was 40,863 482 
bp (SD +/-2,935 bp). 483 
Lambda Red Recombination in Virulent Fosmid Clones. The major hemolysin gene in 484 
fosmid clone A1-A8 was disrupted with lambda Red recombination using methods described 485 
previously (34, 35). Briefly, the kanamycin resistance gene from pKD4 was amplified using 486 
primers listed in Table S1 in Supplementary Materials, which were designed to add 39 bp tails 487 
that were homologous to the sequence targeted for inactivation. Thermal cycler conditions were 488 
as follows: 94°C for 30 sec. for initial denaturation followed by 25 cycles of 94°C for 30 sec., 489 
50°C for 30 sec. and 68°C for 6 min. followed by 68°C for 10 min. for final extension. Fosmid 490 
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clone A1-A8 was transformed with pKD46-Gm (35) using a standard chemical complementation 491 
protocol and subsequently renamed A1-A8-pKD46. Fosmid clone A1-A8-pKD46 was grown 492 
overnight in LB medium containing 10 μg/ml gentamicin and diluted to an OD600 of 0.05 in 5 493 
mL LB medium. The diluted culture was grown at 28°C until the cells reached an OD600 of 0.1 at 494 
which time L-arabinose was added to a concentration of 10 mM. The culture was allowed to 495 
continue to grow to an OD600 of 0.6, at which time it was put on ice for 15 min. At this point, the 496 
standard protocol for producing chemically competent cells was followed. For transformation, 497 
cells were mixed with 0, 20, 50, or 100 ng PCR products amplified from pKD4 containing the 39 498 
bp tails. Confirmation that homologous recombination had taken place within the major 499 
hemolysin gene was done by PCR using confirmation primers listed in Table S1 in 500 
Supplementary Materials. 501 
Construction of Serratia sp. SCBI Transposon Mutant Library. Serratia sp. strain SCBI was 502 
mutagenized by the use of the MiniHimar transposon RB1 (36). Both donor (E. coli S17-1 503 
λpir/pMiniHimar RB1) and recipient (Serratia sp. SCBI) were grown overnight in LB medium 504 
containing appropriate antibiotics (30 µg/ml kanamycin for donor and 10 µg/ml polymyxin B 505 
sulfate for recipient). One milliliter of each culture was centrifuged at 10,000 x g for 2 minutes 506 
and the pellet was washed twice with phosphate-buffered saline (PBS) before 20 μl of a 1:1 cell 507 
mixture was spotted onto the center an LB agar plate and incubated at 37˚C for 24 h. Following 508 
incubation, the cell mixture was resuspended in 1 ml PBS and transconjugants were selected by 509 
overnight growth of 100 μl aliquots from 10-5 and 10-6 dilutions on LB agar containing 100 μg/ml 510 
kanamycin and 30 μg/ml polymyxin B sulfate at 37˚C. A total of 2,100 isolated transconjugant 511 
colonies were selected and grown at 37˚C overnight in LB medium containing 40 μg/ml 512 
kanamycin, 10 μg/ml polymyxin B sulfate in 96-well plates before addition of an equal volume 513 
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of 60% glycerol and storage at -80˚C for future use.  514 
Screening the miniHimar RB1 Transposon Mutant Library for Hemolytic Activity. Minor 515 
modifications were done on a liquid hemolysis assay described previously (7, 37) in order to 516 
screen the Serratia sp. SCBI miniHimar RB1 transposon mutant library. Briefly, individual 517 
mutants were inoculated into 200 μl of LB medium containing 25 μg/ml kanamycin in 96-well 518 
plates and incubated for 18 h at 37°C. Twenty microliters of each culture was mixed with 180 μl 519 
washed sheep red blood cells (SRBCs; 10% v/v in PBS) in 96-well plates and incubated for 45 520 
min. at 37°C with gentle agitation. Plates were centrifuged for 5 min. at 3,000 x g and the 521 
resulting supernatant was diluted 1:10 in dH2O. The A405 was determined on a spectrophotometer 522 
to measure amount of released hemoglobin. As a positive control, 1 ml of SRBCs was lysed by 523 
addition of 100 l of 20% sodium dodecyl sulfate (SDS) and incubated at 37C for 15 min. For 524 
negative controls, 100 l of LB medium was added to 1 ml washed SRBCs incubated at 37C 525 
and samples were treated as described above. Controls were repeated at each temperature in 526 
order to calculate hemolytic units for each sample set at the respective temperature. The 527 
following equation was used to calculate hemolytic units (HU): HU = ((A405 of sample – A405 of 528 
negative control)/A405 of positive control) x 100.  529 
Screening the miniHimar RB1 Transposon Mutant Library for Antibiotic Activity. 530 
Individual colonies of transposon-induced mutants of Serratia sp. strain SCBI were screened for 531 
antibiotic activity by the use an antibiotic overlay plate assay. PP3 agar (2% proteose peptone 3, 532 
0.5% NaCl, 2% agar) was poured into oversized petri dishes (150x15 mm; Fisher Scientific, 533 
Canada). Using a 96-well replicator, the -80C stored transposants were transferred into new 96-534 
well microtiter plates containing fresh LB medium containing 25 μg/ml kanamycin and 535 
incubated overnight at 37C. The freshly grown overnight culture was replica plated directly into 536 
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PP3 medium and the plates were incubated for 18 h at 28°C. A total of 10 mL of 0.8% agar was 537 
mixed with 200 μl of the indicator strain Micrococcus luteus and poured over each inoculated 538 
PP3 plate. The mutants were incubated with the overlay for 24 h at 28°C and zones of clearing 539 
were measured. To test individual mutants for antibiotic activity, the same procedure was 540 
followed however 2 μl of overnight culture was inoculated onto PP3 plates overlaid with the 541 
indicator strain M. luteus. 542 
Screening the miniHimar RB1 Transposon Mutant Library for Swimming Motility. 543 
Individual colonies of transposon-induced mutants of Serratia sp. strain SCBI were screened for 544 
swimming motility by the use of swim plate assay. Swim agar (0.2% agar) was poured into 545 
oversized petri dishes (150x15 mm; Fisher Scientific, Canada). Using a 96-well replicator, the -546 
80C stored transposants were transferred into new 96-well microtiter plates containing fresh LB 547 
medium containing 25 μg/ml kanamycin and incubated overnight at 37C. The freshly grown 548 
overnight culture was replica plated directly into swim plates using a 96-well metal replicator. 549 
The swim plates were incubated for 4 h at 37°C and the diameters of swim rings were measured. 550 
Confirmation of mutants defective in swimming was done using an assay described previously 551 
(7). 552 
Molecular Analysis of Transposon Mutants. Genomic DNA from each clone was prepared 553 
with the standard chloroform-isoamyl alcohol extraction technique. The gDNA was digested 554 
with NsiI (New England Biolabs), which doesn’t cut the transposon, followed by ligation with 555 
T4 ligase (New England Biolabs). The ligated DNA was electroporated into E. coli DH5α λpir 556 
cells and transformants were selected on LB plates containing 25 μg/ml kanamycin. The 557 
transposon-carrying plasmids were isolated and sequenced using the transposon-specific primers 558 
Himar1 (5’-CATTTAATACTAGCGACGCCATCT-3’) and 615 (5’-559 
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TCGGGTATCGCTCTTGAAGGG-3’). Sequences were compared to the Serratia sp. SCBI 560 
genome using BlastN.  561 
The genome sequence and its annotations are available at NCBI under the accession numbers 562 
CP003424 and CP003425. 563 
Gene Complementation. For complementation analysis, the major hemolysin open reading 564 
frame was amplified with primers F-Hemolysin-Comp (5’-CCCACGGCAATATA 565 
CGGAGATACA-3’) and R-Hemolysin-Comp (5’-TGGCTTACAACGTGTTGGATCAGG-3’), 566 
a template of 100 ng Serratia sp. SCBI gDNA, and One-Taq Hot Start DNA Polymerase (New 567 
England Biolabs). The PCR program was 30 sec. at 94C for initial denaturation followed by 30 568 
cycles of 94C for 30 sec., 50C for 30 sec. and 68C for 6 min. with a final extension time of 10 569 
min. at 68C. PCR products were cleaned up using the QIAquick PCR purification kit (Qiagen) 570 
according to manufacturer’s instructions. Approximately 100 ng of cleaned up PCR product was 571 
cloned into vector pCR2.1-TOPO using the TOPO®-TA Cloning kit (Invitrogen) following 572 
manufacturer’s instructions. Invitrogen primers M13 Forward (-20) and M13 Reverse were used 573 
to determine the orientation of gene insertion. Depending on orientation of insertion in pCR2.1-574 
TOPO, plasmid DNA was cut with either XbaI and SacI or with XbaI and HindIII (New England 575 
Biolabs). Digested DNA was ligated into pBAD33Cm (Guzman et al., 1995), which had been 576 
cut with the same restriction enzymes. The vector was subsequently renamed pBAD33-Hemol 577 
and was electroporated into E. coli DH5α λpir and selection was made on LB plates containing 578 
25 μg/ml chloramphenicol. Plasmid was extracted from successfully transformed E. coli DH5α 579 
λpir and electroporated into the appropriate strain and selection was made on LB plates 580 
containing 150 μg/ml chloramphenicol. When assaying for complementation, all strains were 581 
grown in the prescense of 10 mM arabinose to induce expression of the cloned gene. 582 
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Hemolysis Assay. Rates of hemolytic activity for wild-type Serratia sp. SCBI, E. coli EPI300, 583 
fosmid clones, and individual Serratia sp. SCBI transposon mutants were measured at 28°C 584 
using a liquid assay described previously (7), which measured the rate of sheep red blood cell 585 
(SRBC) lysis by bacterial culture (~4.0 x 10
6
 cells) over 4 h.  586 
Insect Viability Assay. E. coli fosmid clones and Serratia sp. SCBI miniHimar RB1 mutants 587 
were analyzed for their ability to kill 3
rd
 instar M. sexta larvae using methods described 588 
previously (Petersen and Tisa, 2012). Briefly, overnight bacterial cultures were initially diluted 589 
to an OD600 of 1.0 in LB medium. For the E. coli fosmid clones, the bacterial culture was further 590 
diluted several-fold to obtain an average CFU value of 1 x 10
5
. For the miniHimar RB1 mutants, 591 
the bacterial culture was further diluted several-fold to obtain an average CFU value of 2 x 10
3
. 592 
For each diluted sample, 10 l was directly injected into the insect hemocoel by use of a 593 
sterilized Hamilton syringe. Wild-type Serratia sp. SCBI and E. coli EPI300 were used as 594 
controls in all experiments. For all of the samples, including the controls, 10 larvae were used. 595 
The larvae were held individually with food for up to 14 days at 37C under a 16 h light/8 h dark 596 
cycle. The larvae were monitored for insect mortality or delays in insect development during that 597 
time period. Mortality was measured as percentage of larvae killed by the bacteria relative to 598 
total number of larvae injected per sample. From these data, the LT50 values were calculated and 599 
defined as the average time required for 50% of the population to die from infection.  600 
Motility Assays. Swimming and swarming motility was assayed for wild-type Serratia sp. SCBI 601 
and all Serratia sp. SCBI mutants using methods described previously with modifications made 602 
only to the percentage of agar used (0.65, 1.05, or 1.5%) (7, 38). For E. coli and fosmid clone 603 
A1-F2, swarming was assayed using LB plates containing 0.5% agar. Briefly, swarm plates were 604 
spotted with 2 μl of overnight culture and incubated for 18 h or longer at 22°C or 28°C. Swim 605 
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plates containing 0.2% agar were stabbed with overnight culture and incubated for 8 h or longer 606 
at 37°C. 607 
RNA Extraction from Swarmer Cells and cDNA Synthesis. To obtain cells for RNA 608 
extraction, cells were collected from the edges of swarming colonies on 0.65% agar incubated at 609 
28°C. Cells were collected when the swarm colonies were at a diameter of 20 mm, 40 mm or 80 610 
mm. The swarmer cells were incubated with RNA Protect (Qiagen) following manufacturer’s 611 
instructions followed by storage at -80°C overnight. RNA extraction was performed using the 612 
RNeasy Mini Kit (Qiagen) following manufacturer’s instructions, followed by treatment with 613 
DNase (New England Biolabs). Four micrograms RNA was reverse transcribed into cDNA using 614 
GoScript
TM
 Reverse Transcriptase (Promega) following manufacturer’s instructions, quantified 615 
with a Qubit® 2.0 Fluorometer (Invitrogen), and diluted to 10 ng/μl. 616 
Analysis of Gene Expression with Quantitative RT-PCR. Amplification and detection of gene 617 
expression was performed using the Stratagene Mx3000P QPCR system (Agilent Technologies). 618 
The primers used for these experiments are listed in Table S1 in Supplementary Materials. The 619 
gene l21p (39) was used as the normalizer for all qRT-PCR experiments. The RT-PCR reactions 620 
were done using 50 ng template cDNA, SYBR Green PCR master mix (Applied Biosystems) and 621 
primer mix (0.3 μM) in a 25 μl reaction mixture. The following thermal cycler parameters were 622 
used: (1) 15 min. at 95°C, (2) 40 cycles of 95°C for 15 s and 60°C for 30 sec, and (3) thermal 623 
disassociation cycle of 95°C for 1 min, 55°C for 30 sec and incremental increases in temperature 624 
to 95°C for 30 sec. Reactions were performed in triplicate and the comparative threshold-cycle 625 
method was used to quantify gene expression. 626 
Statistical Analysis. Data were analyzed by one-way analysis of variance using JMP 10 627 
software (SDS Institute, Inc.). Student’s t-test provided comparisons of means. 628 
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Physiochemical analysis of serrawettin W2. For analysis of strains by Matrix-assisted laser 629 
desorption/ionization (MALDI) mass spectrometry (MS) whole cells were taken from a LB-plate 630 
and spotted with 1 µl of a 20 mM 4-chloro-α-cyanocinnamic acid in 70% acetonitrile with 0.1% 631 
trifluoracetic acid on a stainless steel target and air-dried. MALDI-MS analysis was done with a 632 
MALDI LTQ Orbitrap XL (Thermo Fisher Scientific, Inc., Waltham, MA) equipped with a 633 
nitrogen laser at 337 nm. For calculation of sum formulas, mass spectra were internally 634 
calibrated using calibration mixture 1 (Applied Biosystems, Sequazyme peptide mass standards 635 
kit) and measured as triplicate. Qual Browser (version 2.0.7; Thermo Fisher Scientific, Inc., 636 
Waltham, MA) was used for spectra analysis and to calculate possible sum formulas.   637 
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Table 1. Bacterial strains and plasmids used in this study.  792 
 Description Reference or Source 
Serratia sp. SCBI:   
WT Serratia sp. 
SCBI 
Wild-type Serratia sp. SCBI (3)  
1-C4 Transposon mutant, disrupted shlA This study 
6-E3 Transposon mutant, disrupted shlA This study 
8-E6 Transposon mutant, disrupted shlA This study 
10-F8 Transposon mutant, disrupted shlA This study 
18-A11 Transposon mutant, disrupted shlA This study 
22-C11 Transposon mutant, disrupted putrescine 
importer 
This study 
22-H3 Transposon mutant, disrupted noncoding 
region 
This study 
1-A4 Transposon mutant, disrupted swrA This study 
13-G2 Transposon mutant, disrupted swrA This study 
11-B8 Transposon mutant, disrupted swrA This study 
   
E. coli:   
E. coli S17-1  λpir Donor strain transposon mutagenesis (40)  
E. coli DH5α λpir Host strain for gene complementation (41)  
E. coli EPI300 Host strain for fosmid library Epicentre Technologies 
Fosmid clone A1-A8 Carries Serratia sp. SCBI shlA gene This study 
Fosmid clone A1-F2 Carries Serratia sp. SCBI swrA gene This study 
   
Plasmids:   
pKD46-Gm Lambda Red recombination plasmid (35) 
pKD4 Kanamycin resistance cassette template (34) 
pMiniHimar RB1 Transposon mutagenesis (36) 
pCC1FOS
TM
 Fosmid vector Epicentre Technologies 
pCR2.1-TOPO
®
 TOPO Cloning Invitrogen
TM
 
pBAD33-Cm Expression vector for complementation (42) 
pBAD33-Hemol Complementation of hemolysin gene This study 
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Table 2. Antibiotic activity of the shlA mutants and E. coli fosmid clone A1-F2. 794 
 
Strain 
Radius of Clearing 
Zone (mm)* 
Wild-type Serratia sp. SCBI 14.1 + 1.76 
1-C4 16.2 + 2.36 
6-E3 15.9 + 1.05 
8-E6 17.1 + 1.25 
10-F8 16.8 + 1.89 
18-A11 16.1 + 2.07 
  
Wild-type E. coli EPI300 -- 
Fosmid clone A1-F2 5.9 + 1.56 
* Radii of clearing zones were measured in mm following 24 h of incubation at 28°C with M. 795 
luteus as the indicator strain. Results are shown as the average of 9 measurements from 3 796 
independent experiments, with the standard deviations indicated by +. 797 
--, No activity  798 
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WT Serratia sp. 
SCBI 
93.3% 49.3 + 11.9 51.3 + 2.9 14.5 + 1.1 
WT Serratia sp. 
SCBI + pBAD33 
88.4% 45.0 + 8.3 49.7 + 1.6 14.3 + 1.3 
WT Serratia sp. 
SCBI + pBAD33-
Hemol 
97.9% 53.8 + 6.7 56.7 + 2.4 13.8 + 0.9 
1-C4 2.8% 88.0 + 0  64.3 + 1.9 16.9 + 1.8 
1-C4 + pBAD33 2.2% 88.0 + 0 63.1 + 2.3 16.7 + 1.5 
1-C4 + pBAD33-
Hemol 
86.5% 54.7 + 15.1 49.3 + 2.9 13.2 + 1.7 
A
 Hemolytic activity was measured as the percentage of SRBCs lysed following a 4 h incubation 801 
at 28°C. 802 
B
 Swarm assays were performed at 22°C with an incubation time of 48 h. The diameters of the 803 
swarm rings were measured and these values are expressed as mm. 804 
C
 Swim assays were performed at 37°C with an incubation time of 8 h. The diameters of the 805 
swim rings were measured and these values are expressed as mm. 806 
D
 Antibiotic assays were performed at 28°C with an incubation time of 24 h. The indicator strain 807 
was M. luteus. The radius of the clearing zones were measured and these values are expressed as 808 
mm. 809 
* The maximum measurement was 88 mm (the width of the Petri dish). Results are shown as the 810 
average of 9 measurements from 3 independent experiments, with the standard deviations 811 
indicated by +.  812 
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FIGURE LEGENDS 813 
Figure 1. The virulence and hemolytic activity of E. coli fosmid clone A1-A8 is due to the major 814 
hemolysin gene. (A) Third instar M. sexta larva were injected with 2 x 10
5
 CFU of either wild-815 
type Serratia sp. SCBI (WT SCBI), E. coli fosmid clone A1-A8 (A1-A8), E. coli fosmid clone 816 
A1-A8 with the shlA gene deleted (A1-A8 KO), or wild-type E. coli EPI300 (EPI300). Larva 817 
were held individually at 37°C for 7 d. Mortality was measured as the percentage of the larva 818 
population killed. (B) Hemolytic activity against SRBCs was assessed for wild-type Serratia sp. 819 
SCBI (WT SCBI), E. coli fosmid clone A1-A8 (A1-A8), E. coli fosmid clone A1-A8 with the 820 
shlA gene deleted (A1-A8 KO), and wild-type E. coli EPI300 (EPI300).  A total of > 4.0 x 10
6
 821 
CFU was used for each bacterial strain and the rate of hemolysis was measured over 4 h at 28°C. 822 
Error bars represent standard deviations from at least two independent experiments. 823 
 824 
Figure 2. Loss of shlA results in a significant reduction or loss of hemolytic activity in Serratia 825 
sp. SCBI. (A) Hemolytic activity against SRBCs by wild-type Serratia sp. SCBI and five 826 
hemolysin mutants (> 4.0 x 10
6
 CFU) was measured over 4 h at 28°C. Error bars represent 827 
standard deviations from at least two independent experiments. (B) Representation of the results 828 
of rescue cloning the hemolysis mutants; 5 of the 7 hemolysis mutants had the transposon 829 
insertion in shlA and all hit in a different location within the gene. 830 
 831 
Figure 3. Transposon insertion into shlA influenced both swimming and swarming motility. (A) 832 
Photographs of wild-type Serratia sp. SCBI and the shlA mutants following 18 h at 22°C on 833 
0.65% agar PP3 swarm plates. (B) Photographs of wild-type Serratia sp. SCBI and the shlA 834 
mutants following 48 h at 28°C on 1.5% agar PP3 swarm plates. (C) Photographs of wild-type 835 
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Serratia sp. SCBI and the shlA mutants following 8 h at 37°C in 0.2% agar swim plates. (D) 836 
Summary of swarm and swim ring diameters of wild-type Serratia sp. SCBI and the hemolysis 837 
mutants. The maximum measurement was 88 mm (the width of the Petri dish). Results are 838 
shown as the average of 9 measurements from 3 independent experiments, with the standard 839 
deviations indicated by +. 840 
 841 
Figure 4. Inactivation of flhC resulted in loss of swimming and swarming motility but did not 842 
influence hemolytic activity. (A) Photographs of wild-type Serratia sp. SCBI and flhC mutant 843 
12-H4 following 8 h of incubation at 37°C in 0.2% agar plates. (B) Photographs of wild-type 844 
Serratia sp. SCBI and flhC mutant 12-H4 following 42 h of incubation at 28°C on 0.65% agar 845 
PP3 swarm plates. (C) Hemolytic activity against SRBCs by wild-type Serratia sp. SCBI and 846 
flhC mutant 12-H4 (> 4.0 x 10
6
 CFU) was measured over 4 h at 28°C. Error bars represent 847 
standard deviations from at least two independent experiments. 848 
 849 
Figure 5. Mutants with transposon insertions in shlA had significantly increased mRNA levels of 850 
the 17,775 bp NRPS swrA when swarming. qRT-PCR was performed on RNA extracted from 851 
swarmer cells on 0.65% agar PP3 plates. mRNA levels were normalized to the l21p 852 
housekeeping gene and compared to the calibrator wild-type Serratia sp. SCBI (WT SCBI). Data 853 
are presented as the relative changes in gene expression between the values obtained with the test 854 
conditions and the calibrator. (A) A comparison of flhD, fliC, and swrA mRNA levels when 855 
swarm ring diameters were at 40 mm between wild-type Serratia sp. SCBI and the five shlA 856 
mutants. (B) mRNA levels of flhD, fliC, and swrA by wild-type Serratia sp. SCBI and shlA 857 
mutant 6-E3 at swarm ring diameters of 20, 40, and 80 mm. Error bars represent standard 858 
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deviations from at least two independent experiments. * (p-value <0.05) denotes significant 859 
differences in relative mRNA levels. 860 
 861 
Figure 6. Mutations in swrA had various effects on antibiotic activity and these effects were 862 
dependent on the site of transposon insertion in swrA. (A) Rescue cloning showed that mutants 863 
1-A4, 13-G2 and 11-B8 had the transposon insertion at different sites within swrA. (B) The 864 
domain structure of SwrA. (C) Wild-type Serratia sp. SCBI and the swrA mutants were spot 865 
inoculated onto PP3 plates, incubated for 48 h at 28°C, killed by chloroform, and overlaid with 866 
warm 0.8% agar containing Micrococcus luteus. Clearing zones were observed following 24 h at 867 
28°C. Results are shown as the average of 9 measurements from 3 independent experiments, 868 
with the standard deviations indicated by +. 869 
 870 
Figure 7. Mutations in swrA had various effects on swarming and swimming motility. (A) 871 
Photographs of wild-type Serratia sp. SCBI and swrA mutants 1-A4, 13-G2, and 11-B8 872 
following 24 h and 48 h incubation at 28°C on 0.65% agar PP3 plates. (B) Photographs of wild-873 
type Serratia sp. SCBI and swrA mutants on 1.05% agar PP3 plates following 24 h and 48 h 874 
incubation at 28°C. (C) Photographs of wild-type Serratia sp. SCBI and swrA mutants in 0.2% 875 
agar plates following 8 h at 37°C. (D) Summary of swarm and swim ring diameter measurements 876 
observed for wild-type Serratia sp. SCBI and the swrA mutants. Results are shown as the 877 
average of 9 measurements from 3 independent experiments, with the standard deviations 878 
indicated by +. 879 
 880 
Figure 8. The swrA mutant 1-A4 was the only swrA mutant to display defective virulence and 881 
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hemolytic activity. (A) Third instar M. sexta larva were injected with 2 x 10
4 
CFU of either wild-882 
type Serratia sp. SCBI or one of the swrA mutants (1-A4, 11-B8, or 13-G2) and kept at 37°C for 883 
7 d. Mortality was measured as the percentage of the larva population killed over time. (B) 884 
Hemolytic activity against SRBCs by either wild-type Serratia sp. SCBI or one of the swrA 885 
mutants (1-A4, 11-B8, or 13-G2) at > 4.0 x 10
6
 CFU was measured over 4 h at 28°C. Error bars 886 
represent standard deviations from at least two independent experiments. (C) The growth rate of 887 
each strain was measured over 24 h at 37°C by absorbance at 600 nm.  888 
 889 
Figure 9. E. coli fosmid clone A1-F2, which contains the swrA gene, showed increased 890 
swimming and swarming motility compared to wild-type E. coli EPI300. (A) Photographs of 891 
fosmid clone A1-F2 and wild-type E. coli EPI300 following 8 h incubation at 37°C in 0.2% agar 892 
swim plates. (B) Photographs of fosmid clone A1-F2 and wild-type E. coli EPI300 following 18 893 
h at 28°C on 0.5% agar LB swarm plates. (C) Summary of swarm and swim ring diameter 894 
measurements observed for fosmid clone A1-F2 and wild-type E. coli EPI300. Results are shown 895 
as the average of 9 measurements from 3 independent experiments, with the standard deviations 896 
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